Treatment of idiopathic inflammatory myopathies using a population of CD19 car-expressing cells
TW202629785APending Publication Date: 2026-07-16NOVARTIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141419
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-28
- Filing Date
- 2025-10-27
- Publication Date
- 2026-07-16
Abstract
The invention provides methods of using a population of CD19 CAR-expressing cells (for example, rapcabtagene autoleucel) for treating idiopathic inflammatory myopathies. Also disclosed are methods of making a population of CD19 CAR-expressing cells.
Need to check novelty before this filing date? Find Prior Art